C-Path Looks to Speed Gene Based Therapies Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic bluepr
Future of medicine – the critical path forward I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This
Critical Path Institute Announces New Head of Operations Critical Path Institute (C-Path) has announced that Steven T. Broadbent has been chosen as the next chief operating officer of C-P
House Energy and Commerce Committee Hearing C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hear
Critical Path Institute Announces New Board Members Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2
Critical Path Institute Honors World Tuberculosis Day 2012 Tuberculosis (TB) is often thought to be a disease of the past. The reality: Because no new therapies for TB have been developed i
Could Genetics Improve Warfarin Dosing? In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of th
Critical Path Institute Announces New CEO Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chi
European Medicines Agency Deems Imaging Biomarker a Qualified Measure to Select Patients with Early Stages of Cognitive Impairment for Alzheimer’s Disease Clinical Trials Based on a request for regulatory review by Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD), the